Following the publication of the US food and drug administration safety and innovation act (FDASIA) in 2012, and the subsequent establishment of a public docket in july 2013, the FDA announced its…
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00161
- Awardee
-
Universitat ST. Gallen UEI LLK6D5M1UAF1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $764,418
Award facts
- Opportunity
-
- FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2100123 · Posted Nov 20, 2020
- Contract value 100% obligated
- $764,418.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Other Administrative Action | $372,659 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $391,759 |
About this award
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023.
The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science for fiscal year 2021, which solicits research and development proposals across eight areas of regulatory science to modernize various aspects of the FDA's regulatory functions. This contract represents a renewal of a prior year BAA focused on supporting the FDA's mission to protect and promote public health through regulatory science activities to be performed in Silver Spring, Maryland. There is no set-aside designation associated with this contract.
Description
Following the publication of the US food and drug administration safety and innovation act (FDASIA) in 2012, and the subsequent establishment of a public docket in july 2013, the FDA announced its intention to examine the use of selected quality metr
Quick answers
Who was awarded contract 75F40121C00161?
75F40121C00161 was awarded to Universitat ST. Gallen by Food and Drug Administration (Department of Health and Human Services) on September 28, 2021.
How much is contract 75F40121C00161 worth?
The government has obligated $764,418 on 75F40121C00161.
Was contract 75F40121C00161 competed?
The extent of competition for 75F40121C00161 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award